Evidence map›Paper›PMID 21223980›Full record

ArticleBiochimica et biophysica acta2011

Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.

António Pedro Gonçalves, Valdemar Máximo, Jorge Lima, Keshav K Singh, Paula Soares, Arnaldo Videira

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Long non-coding RNA UCA1 regulates MPPMetabolic brain disease · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Non-Canonical Cell Death Induced by p53.International journal of molecular sciences · 2016
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Subamolide a induces mitotic catastrophe accompanied by apoptosis in human lung cancer cells.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

António Pedro GonçalvesIBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. apgoncalves@ibmc.up.pt
Valdemar Máximo
Jorge Lima
Keshav K Singh
Paula Soares
Arnaldo Videira
Universidade do Porto · PTRoswell Park Comprehensive Cancer Center · US

Funding

Mitochondria and CarcinogenesisR01CA121904 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SINGH, KESHAV K · 2006 to 2010
$1.5M
NCI NIH HHS R01 CA121904
6 · The paper itself

Abstract

In order to investigate the cell death-inducing effects of rotenone, a plant extract commonly used as a mitochondrial complex I inhibitor, we studied cancer cell lines with different genetic backgrounds. Rotenone inhibits cell growth through the induction of cell death and cell cycle arrest, associated with the development of mitotic catastrophe. The cell death inducer staurosporine potentiates the inhibition of cell growth by rotenone in a dose-dependent synergistic manner. The tumor suppressor p53 is involved in rotenone-induced cell death, since the drug treatment results in increased expression, phosphorylation and nuclear localization of the protein. The evaluation of the effects of rotenone on a p53-deficient cell line revealed that although not required for the promotion of mitotic catastrophe, functional p53 appears to be essential for the extensive cell death that occurs afterwards. Our results suggest that mitotic slippage also occurs subsequently to the rotenone-induced mitotic arrest and cells treated with the drug for a longer period become senescent. Treatment of mtDNA-depleted cells with rotenone induces cell death and cell cycle arrest as in cells containing wild-type mtDNA, but not formation of reactive oxygen species. This suggests that the effects of rotenone are not dependent from the production of reactive oxygen species. This work highlights the multiple effects of rotenone in cancer cells related to its action as an anti-mitotic drug.

Indexed as

Antineoplastic Agents, PhytogenicCell CycleCell DeathCell Line, TumorCell ProliferationCellular SenescenceDrug SynergismEnzyme InhibitorsFabaceaeHumansMitochondriaMitosisReactive Oxygen SpeciesRotenoneStaurosporineThyroid NeoplasmsAntineoplastic Agents, PhytogenicEnzyme InhibitorsReactive Oxygen SpeciesRotenoneStaurosporineTumor Suppressor Protein p53Uncoupling Agents

Identifiers

PMID21223980
PMCPMC3051352
OpenAlexW2148771747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.